Skip to navigation Skip to main content
preloader
  • Home
  • About Us
  • Technologies & Applications
    • Regenerative Medicine Applications | Amniotic Fluid Stem Cells
    • Regenerative Medicine Applications | Exosomes
    • Aesthetic Medicine Applications | Deer-Derived Exosomes
    • Healthcare & Wellness Series | Deer Velvet Antler Peptide ACT.A
  • New Drug Development
  • i-ExoCraft®
  • News & Updates
    • Video Gallery
    • Press Coverage
      • Drug Development & Regulatory Affairs
      • Technology Platform & R&D
      • International Expansion & Out-Licensing
      • Products & Commercial Partnerships
  • Investor Relations
  • Contact Us
  • English
    • Chinese (Traditional)

Operational and financial performance

Yonglirong’s revenue/March was 10.56 million yuan, an annual increase of 24.2%, a new high of 26.7 million yuan in the first quarter

Yonglirong (6973) announced on the 7th that its revenue in March 2026 was 10.56 million yuan, an annual increase of 24.25% and a monthly increase of 30.43%; the cumulative first quarter of 2026...
Continue reading

Dual engine assist! Yonglirong’s first-quarter revenue reached 26.7 million yuan, a new high for the same period

Yonglirong (6973)'s consolidated revenue in March reached 10.56 million yuan, a monthly increase of 30.43% and an annual increase of 24.25%; the cumulative first quarter consolidated revenue reached...
Continue reading

Tel: 02-2697-5599 | Email: service@u-neuron.com | Address: 18F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan

Copyright © 2026 All Rights Reserved.

Tel: 02-2697-5599
Email: service@u-neuron.com
Address: 18F.-5, No. 99, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City, Taiwan

Copyright © 2026 All Rights Reserved.

  • Home
  • About Us
  • Technologies & Applications
    • Regenerative Medicine Applications | Amniotic Fluid Stem Cells
    • Regenerative Medicine Applications | Exosomes
    • Aesthetic Medicine Applications | Deer-Derived Exosomes
    • Healthcare & Wellness Series | Deer Velvet Antler Peptide ACT.A
  • New Drug Development
  • i-ExoCraft®
  • News & Updates
    • Video Gallery
    • Press Coverage
      • Drug Development & Regulatory Affairs
      • Technology Platform & R&D
      • International Expansion & Out-Licensing
      • Products & Commercial Partnerships
  • Investor Relations
  • Contact Us
  • English
    • Chinese (Traditional)
  • 聯繫顧問
  • 索取資料
  • 預約會議
English Chinese (Traditional)
EnglishChinese (Traditional)